Lite Strategy Inc (0JW9.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 0
Cost of Revenue 169,000 61,000 368,000 -247,000
Gross Profit -169,000 -61,000 -368,000 247,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,405,000 3,143,000 5,189,000 4,011,999
Operating Expenses 2,774,000 3,451,000 8,352,000 7,956,000
Operating Income -2,774,000 -3,451,000 -8,352,000 -18,980,000
Interest Expense 0 0 0 0
Income Before Tax -2,573,000 -2,677,000 -8,007,000 -18,406,000
Income Tax Expense 0 0 0 0
Net Income -2,573,000 -2,677,000 -8,007,000 -18,406,000
Per Share
EPS -0.39 -0.40 -1.20 -2.76
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30
Revenue 0 65,297,000 48,816,000
Cost of Revenue 0 383,000 1,815,000
Gross Profit 0 64,914,000 47,001,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 13,532,000 23,295,000 33,130,000
Operating Expenses 17,455,000 34,785,000 85,580,000
Operating Income -17,455,000 14,542,000 -36,764,000
Interest Expense 0 0 0
Income Before Tax -15,945,000 17,778,000 -31,838,000
Income Tax Expense 0 0 -4,948,000
Net Income -15,945,000 17,778,000 -31,840,000
Per Share
EPS -2.39 2.67 -4.78
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30
Assets
Cash and Cash Equivalents 18,011,000 3,705,000 16,906,000
Short Term Investments 0 34,640,000 83,787,000
Net Receivables 0 0 85,000
Inventory 0 0 0
Total Current Assets 18,285,000 40,769,000 107,528,000
Property Plant Equipment 0 606,000 13,281,000
Goodwill and Intangibles 0 0 0
Total Assets 18,285,000 41,375,000 120,809,000
Liabilities
Account Payables 176,000 3,168,000 6,134,000
Short Term Debt 0 0 2,856,000
Total Current Liabilities 1,354,000 8,355,000 20,340,000
Long Term Debt 0 0 11,300,000
Total Liabilities 1,354,000 8,355,000 96,185,000
Shareholders Equity
Retained Earnings -404,164,000 -388,219,000 -405,997,000
Total Shareholders Equity 16,931,000 33,020,000 24,624,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30
Assets
Cash and Cash Equivalents 18,011,000 3,705,000 16,906,000
Short Term Investments 0 34,640,000 83,787,000
Net Receivables 0 0 85,000
Inventory 0 0 0
Total Current Assets 18,285,000 40,769,000 107,528,000
Property Plant Equipment 0 606,000 13,281,000
Goodwill and Intangibles 0 0 0
Total Assets 18,285,000 41,375,000 120,809,000
Liabilities
Account Payables 176,000 3,168,000 6,134,000
Short Term Debt 0 0 2,856,000
Total Current Liabilities 1,354,000 8,355,000 20,340,000
Long Term Debt 0 0 11,300,000
Total Liabilities 1,354,000 8,355,000 96,185,000
Shareholders Equity
Retained Earnings -404,164,000 -388,219,000 -405,997,000
Total Shareholders Equity 16,931,000 33,020,000 24,624,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30
Operating Activities
Net Income -15,945,000 17,778,000 -31,838,000
Depreciation & Amortization 368,000 383,000 386,000
Stock Based Compensation -144,000 2,278,000 3,589,000
Change in Working Capital 0 -84,276,000 -24,947,000
Operating Cash Flow -20,844,000 -50,473,000 -52,484,000
Investing Activities
Capital Expenditure 0 -7,000 -35,000
Investments 0 -7,000 -35,000
Investing Cash Flow 35,150,000 49,140,000 53,690,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 0 0 -40,000
Dividends Paid 0 -11,660,000 0
Financing Cash Flow 0 -11,868,000 -40,000
Summary
Free Cash Flow -20,844,000 -50,480,000 -52,519,000
Net Change in Cash 14,306,000 -13,201,000 1,166,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30
Operating Activities
Net Income -15,945,000 17,778,000 -31,838,000
Depreciation & Amortization 368,000 383,000 386,000
Stock Based Compensation -144,000 2,278,000 3,589,000
Change in Working Capital 0 -84,276,000 -24,947,000
Operating Cash Flow -20,844,000 -50,473,000 -52,484,000
Investing Activities
Capital Expenditure 0 -7,000 -35,000
Investments 0 -7,000 -35,000
Investing Cash Flow 35,150,000 49,140,000 53,690,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 0 0 -40,000
Dividends Paid 0 -11,660,000 0
Financing Cash Flow 0 -11,868,000 -40,000
Summary
Free Cash Flow -20,844,000 -50,480,000 -52,519,000
Net Change in Cash 14,306,000 -13,201,000 1,166,000